HomePGEN • NASDAQ
add
Precigen Inc
Previous close
$1.18
Day range
$1.10 - $1.21
Year range
$0.65 - $1.93
Market cap
344.12M USD
Avg Volume
1.87M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 953.00K | -30.89% |
Operating expense | 21.21M | 2.05% |
Net income | -23.98M | -21.13% |
Net profit margin | -2.52K | -75.28% |
Earnings per share | -0.09 | -12.50% |
EBITDA | -20.59M | -6.75% |
Effective tax rate | -0.05% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 28.63M | -61.18% |
Total assets | 83.47M | -56.22% |
Total liabilities | 28.10M | -34.67% |
Total equity | 55.38M | — |
Shares outstanding | 292.87M | — |
Price to book | 6.21 | — |
Return on assets | -67.87% | — |
Return on capital | -96.09% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -23.98M | -21.13% |
Cash from operations | -22.73M | -33.66% |
Cash from investing | 5.65M | -46.29% |
Cash from financing | 32.13M | — |
Net change in cash | 15.12M | 328.46% |
Free cash flow | -14.67M | -61.55% |
About
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
Founded
May 21, 1998
Website
Employees
202
